Preclinical characterization of GSK532, a novel STING agonist with potent anti-tumor activity

被引:10
|
作者
Yang, Jingsong [1 ]
Adam, Michael [1 ]
Clemens, Jim [1 ]
Creech, Katrina [1 ]
Schneck, Jess [1 ]
Pasikanti, Kishore [1 ]
Jean-Luc Tran [1 ]
Joglekar, Devika [1 ]
Hopson, Chris [1 ]
Pesiridis, Scott [1 ]
Ramanjulu, Joshi [1 ]
Lian, Yiqian [1 ]
Adams, Jerry L. [1 ]
Smothers, James [1 ]
Hoos, Axel [1 ]
机构
[1] GlaxoSmithKline, Collegeville, PA USA
关键词
D O I
10.1158/1538-7445.AM2018-5554
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5554
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Preclinical Studies of a Novel Anti-Tumor Prodrug Therapy
    Wang, Jing-Hung
    Zhao, Ming
    Barak, Yoram
    Hoffman, Robert M.
    Matin, A. C.
    MOLECULAR THERAPY, 2009, 17 : S109 - S109
  • [22] In vivo programmed myeloid cells expressing novel chimeric antigen receptors show potent anti-tumor activity in preclinical solid tumor models
    Argueta, Shannon
    Wang, Yuxiao
    Zhao, Hongyun
    Diwanji, Neha
    Gorgievski, Michael
    Cochran, Edward
    Grudzien-Nogalska, Ewa
    D'Alessandro, Josephine
    Mccreedy, Bruce
    Prod'homme, Thomas
    Hofmeister, Robert
    Ding, Jian
    Getts, Daniel
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] The combination of a STING agonist with cytokines results in robust anti-tumor effects in autochthonous tumor models
    Blaj, Cristina
    Li, Yingjoy
    Chen, Allen
    Descien, Anthony
    Francica, Brian
    McWhirter, Sarah
    Picton, Lora
    Garcia, K. Christopher
    Raulet, David
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [24] SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis
    Song, Chunying
    Liu, Dong
    Liu, Suxing
    Li, Di
    Horecny, Ivana
    Zhang, Xinzhu
    Li, Puhui
    Chen, Lei
    Miller, Matthew
    Chowdhury, Rasheduzzaman
    Issa, Mena
    Shen, Ru
    Yan, Yinfa
    Zhang, Fengqi
    Zhang, Lei
    Zhang, Limin
    Bai, Chang
    Feng, Jun
    Zhuang, Linghang
    Zhang, Rumin
    Li, Jing
    Wilkinson, Hilary
    Liu, Jian
    Tao, Weikang
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [25] A highly selective and potent TLR8 agonist ZG0895 in preclinical studies of anti-tumor activities
    Cui, Dawei
    Liu, Ruifeng
    Yang, Huanyi
    Zhu, Bing
    Sheng, Zelin
    Lv, Binhua
    CANCER RESEARCH, 2023, 83 (07)
  • [26] SHR1032, a novel STING agonist, stimulates anti-tumor immunity and directly induces AML apoptosis
    Chunying Song
    Dong Liu
    Suxing Liu
    Di Li
    Ivana Horecny
    Xinzhu Zhang
    Puhui Li
    Lei Chen
    Matthew Miller
    Rasheduzzaman Chowdhury
    Mena Issa
    Ru Shen
    Yinfa Yan
    Fengqi Zhang
    Lei Zhang
    Limin Zhang
    Chang Bai
    Jun Feng
    Linghang Zhuang
    Rumin Zhang
    Jing Li
    Hilary Wilkinson
    Jian Liu
    Weikang Tao
    Scientific Reports, 12
  • [27] STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
    Da, Yanyan
    Liu, Yuxia
    Hu, Yuan
    Liu, Wenzeng
    Ma, Junpeng
    Lu, Nan
    Zhang, Chengsheng
    Zhang, Cai
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [28] JNJ-'6196: A next generation STING agonist with potent preclinical activity by the IV route
    Chan, Szeman Ruby
    Bignan, Gilles
    Pierson, Emily
    Mahady, Sally
    Ta, Hayley
    Schepens, Wim
    Thuring, Jan Willem
    Lim, Heng Keang
    Otieno, Monicah
    Wilde, Thomas
    Singer, Monica
    Bogdan, Nancy
    Patel, Shefali
    Luistro, Leo
    Campion, Liam
    Smith, Melissa
    Wiley, Diana
    Packman, Kathryn
    Allegrezza, Michael
    Morgan, Caitlin
    Sendecki, Jocelyn
    Van Aller, Glenn
    Krosky, Daniel
    Connolly, Peter
    Edwards, James
    Staquet, Kim
    Emanuel, Stuart L.
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Novel anti-tumor activity of targeted LSD1 inhibition by GSK2879552
    Mohammad, H.
    Smitheman, K.
    Van Aller, G.
    Cusan, M.
    Kamat, S.
    Liu, Y.
    Johnson, N.
    Hann, C.
    Armstrong, S.
    Kruger, R.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 72 - 72
  • [30] STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity
    Glickman, Laura Hix
    Kanne, David B.
    Kasibhatla, Shailaja
    Li, Jie
    Pferdekamper, AnneMarie Culazzo
    Gauthier, Kelsey Sivick
    Deng, Weiwen
    Desbien, Anthony L.
    Katibah, George E.
    Leong, Justin J.
    Sung, Leonard
    Metchette, Ken
    Ndubaku, Chudi
    Zheng, Lianxing
    Cho, Charles
    Feng, Yan
    McKenna, Jeffrey M.
    Tallarico, John A.
    Bender, Steven L.
    Dubensky, Thomas W.
    McWhirter, Sarah M.
    CANCER RESEARCH, 2016, 76